NEWS
Gene Weaver selected as ARIA R&D Creator to tackle 50-year-old mitochondrial engineering challenge
Gene Weaver Ltd has been selected as an R&D Creator on the Advanced Research + Invention Agency’s (ARIA) Precision Mitochondria programme, a national, multi-year initiative backed by up to £66m and led by Programme Director Ryan Olf.
The Precision Mitochondria...
The UK can build a bioeconomy that works for people, planet and business
By Jen Vanderhoven, CEO of the BBIA and the BioRevolution Coalition.
Every day, we use products that depend on fossil resources without giving it much thought. The ingredients in our cleaning products. The materials used to package food. The chemicals...
Digital Visibility in the Bioscience Industry: How Easily Can Your Business Be Found?
For businesses working across bioscience and life sciences, being visible to the right audience can be an important part of building relationships, communicating expertise and creating new opportunities. But the way potential customers, research partners, investors and industry professionals...
£50m funding available for West Midlands life sciences
Life sciences firms in the West Midlands can apply for a share of £50m in funding from the Local Innovation Partnerships Fund to help develop and scale their near to market products and services.
Expressions of interest (EOI) can be...
Lecture explores how nature could inspire smarter membranes
Professor Alan Goddard, professor of biotechnology and head of biosciences at Aston University, will give a public lecture about his research into bioinspired membranes on 21 October 2026.
His inaugural lecture, Overcoming Separation Anxiety: Building Better Bioinspired Membranes, will explore...
High RNA Quality FFPE Tissue Blocks for Biomarker Discovery
Amsbio has expanded its range of high-quality FFPE tissues and controls specifically designed to support biomarker discovery, histopathology, translational research and assay development.
Although the tissue structure in FFPE samples is maintained for histological analysis, damage to the RNA incurred...
Medicines Discovery Catapult invests in UK biotech pioneers developing novel treatments for chronic diseases
Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.
Two UK biotechs developing novel approaches to treating diseases such as psoriasis and Parkinson’s have secured investment and strategic...
Early Detection of H5N1: The Role of Rapid Antigen Testing in Antarctic Research
Three Decades of Avian Flu
The strain of Avian Influenza known as HPAI H5 has been known to scientists since 1959, when it was first detected in domesticated chickens in Scotland. However, its currently circulating highly pathogenic sub-strain, H5N1, was...
£46m backing for next generation of innovative UK science-led startups
The British Business Bank will commit up to £46m to the Zinc Science-for-Impact Fund.
The Bank has agreed to commit up to £46 million to Zinc Capital Management’s second institutional fund, the Science-for-Impact Fund, to accelerate the development of innovative UK deep...
Precise dosing valve developed for demanding laboratory and analytical systems
Flow control specialist Bürkert has announced the release of a new dosing valve with media separation that offers minimal internal volume, fast switching times and high repeatability to ensure stable processes and reproducible results. Maximum utilisation starts with minimal...
Room temperature cell preservation technology
Amsbio announce a new partnership with Atelerix to introduce its patented hydrogel technology for the room-temperature storage and transportation of living cells, tissues, organoids and viruses.
Preserving cell functionality during storage and transportation is challenging for cell-based therapies as cryopreservation...
Are We Communicating with Trial Participants or Helping Them Understand?
Clinical trials invest considerable effort in helping people understand a study before they join. Maintaining that understanding over the months or years that follow is a different challenge.
Marina Hickson is Managing Director of Vivanti Europe, working at the intersection...
Stem Cell Medium demonstrates best workflow efficiency and lowest cost per well
StemFit Basic04CT from Amsbio is an animal-origin-free, defined, ready-to-use medium designed to support seamless human pluripotent stem cell culture—from iPSC establishment through expansion, and from research to clinical manufacturing. Its simplified one-bottle formulation streamlines process development while reducing workflow...
Memory Restored: A Paradigm-Shifting Alzheimer’s Discovery
Alzheimer’s disease affects millions of lives directly and indirectly every single day. Due to its profound global impact, substantial investment from governments, charities, and industry continues to support research aimed at understanding, preventing, and treating what has long been...
Precision engineered cell mimics for flow cytometry.
Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls.
Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres...
High-sensitivity immunofluorescence with no species or isotype constraints
Utilising enzyme-free DNA nanotechnology, immunoMUSE® kits from Amsbio enable researchers to perform ultra-sensitive, 2-plex to 4-plex custom biomarker detection in tissue while generating same-day imaging results without species or isotype constraints.
Traditionally, tissue immunofluorescence techniques have required compromises. Researchers working...
Intelligent sub loops can optimise hygiene for ultra-pure water applications
Maintaining hygienic flow conditions in purified water (PW) and water for injection (WFI) sub-loops, a critical challenge is minimising the biofilm risk. Traditional approaches like monitored T-valve systems fail to guarantee consistent conditions, while the geometry of Coriolis flow...
Turning Drug Resistance into a Therapeutic Opportunity in Sarcoma
Drug resistance remains one of the greatest challenges in cancer treatment. While many therapies initially succeed in slowing tumour growth, cancer cells can adapt over time, rendering previously effective treatments ineffective (1). For patients with advanced soft tissue sarcoma,...
OSHA compliance and awareness in bioscience and laboratory environments
Bioscience and laboratory work depends on precision, but safe practice also depends on awareness. Researchers, technicians, production teams, and support staff may work near chemicals, biological materials, specialist equipment, or controlled processes. OSHA safety training gives laboratory and bioscience...
Well-characterised biospecimens assist development of cancer immunotherapies
Amsbio report how its biospecimens were used in a large-scale immuno-oncology study analysing Fibroblast Activation protein (FAP) expression across 23 tumour types, contributing to new insights into biomarker development for cancer immunotherapies.
Scientists at Roche Pharma Research used both immunohistochemistry...
Validated monospecific recombinant and monoclonal antibodies
Amsbio has expanded its diverse range of recombinant and monoclonal antibodies to include over 10,000 new validated monospecific products in 15,000 formulations to support research in cancer, immunology, neuroscience, and signal transduction.
Every antibody in the new catalogue has been...
Glasgow health tech firm secures £2m grant to transform medicine inhalation
Nebu~Flow® has been awarded a £2m Scottish Enterprise grant to accelerate development and patient access to its patented nebuliser technology in the UK and globally.
The technology is designed to improve how people receive inhaled medicines, paving the way for...
Funding will enable cutting-edge heart research
Researchers at UK universities are launching a major new research project which aims to create the world’s most detailed 3D images of the mechanical forces at work inside a living, beating heart.
The £4 million award from the Wellcome Trust...
Why high performance cultures break down under pressure in bioscience organisations
High performance in bioscience organisations rarely breaks down because people aren’t capable. It breaks down when scientific, regulatory and commercial pressure increases, but the systems supporting performance don’t evolve with it. What looks like a talent or execution issue...
Longitude Prize on ALS awards £2 million to 20 international teams
The Longitude Prize on ALS is awarding £2 million to 20 of the world’s most promising multidisciplinary teams of innovators using AI to find new drug targets for ALS (amyotrophic lateral sclerosis) – the most common form of MND...
Biochemical Society Research Support Award winners announced
Two members of Aston Institute for Membrane Excellence (AIME), Helen Elwood and Paul Knobbs, have won the Biochemical Society 2027 Research Support Award.
The award is presented to an individual or team demonstrating an outstanding contribution and impact to a...
£439,000 Leverhulme Trust grant to research membrane protein folding
Aston Institute for Membrane Excellence (AIME) has won a £438,674 Research Project Grant from the Leverhulme Trust to carry out fundamental research into how membrane proteins fold correctly.
The proteins that make up the body are made at membranes in...
Pharma Has Enough Training. The Real Gap Is Field Readiness.
The most dangerous mistake is assuming that completion means readiness.
A representative may finish every module and pass every assessment yet still struggle with an HCP. As launches grow more complex and access becomes limited, pharma organisations must look beyond...
Top quality fresh blood products with next day delivery
Amsbio announce the availability of fresh whole blood products from diverse, healthy donors now with overnight delivery in the US, Europe and the UK in conjunction with sister company - Research Donors. All these premium human blood biospecimens undergo...
Extensive range of independently verified cell lines.
Amsbio has launched a new range of authenticated cell lines covering a wide range of tumours, tissues, and species.
With this addition of greater than 1000 independently verified human and animal cell lines, versatile primary and stem cells, the expanded...
